Chimeric Therapeutics Limited
CHMMF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,573 | -$2,858 | -$14,974 | $2,444 |
| Dep. & Amort. | $545 | $487 | $0 | $487 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $385 | $701 | $0 | $318 |
| Change in WC | -$214 | $0 | $3,579 | $0 |
| Other Non-Cash | $2,230 | -$979 | $8,505 | -$7,906 |
| Operating Cash Flow | -$4,627 | -$2,649 | -$2,890 | -$4,657 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$26 | $26 | -$23 | $23 |
| Investing Cash Flow | -$26 | $26 | -$23 | $23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$86 | $0 | -$910 |
| Stock Issued | $0 | $0 | $3,764 | $6,780 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,457 | $4,675 | $2,397 | $6,780 |
| Financing Cash Flow | $5,457 | $4,589 | $2,397 | $5,870 |
| Forex Effect | -$115 | $49 | $21 | -$25 |
| Net Chg. in Cash | -$5,068 | $5,068 | -$472 | -$1,844 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,068 | $0 | $3,525 | $5,370 |
| End Cash | $0 | $5,068 | $3,053 | $3,525 |
| Free Cash Flow | -$4,627 | -$2,649 | -$2,890 | -$4,657 |